
| ID | 69790 |
| フルテキストURL | |
| 著者 |
Tanaka, Takaaki
Department of Respiratory Medicine, Okayama University Hospital
Makimoto, Go
Department of Respiratory Medicine, Okayama University Hospital
Sumii, Ryohei
Department of General Internal Medicine, NHO Fukuyama Medical Center
Omote, Rika
Department of Pathology, NHO Fukuyama Medical Center
Ando, Yayoi
Clinical Research Support Office, National Cancer Center Hospital
Ninomiya, Kiichiro
Center for Comprehensive Genomic Medicine, Okayama University Hospital
Kaken ID
Ohashi, Kadoaki
Department of Respiratory Medicine, Okayama University Hospital
ORCID
Kaken ID
researchmap
Maeda, Yoshinobu
Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
Kaken ID
researchmap
|
| 抄録 | This case report describes a 70-year-old female with cancer of unknown primary origin (CUP) who exhibited multiple distant lymph node metastases. Despite conventional chemotherapy (carboplatin and paclitaxel) and immunotherapy (nivolumab), disease progression was noted. Genomic profiling revealed MET amplification, leading to the administration of capmatinib, a selective MET tyrosine kinase inhibitor. The patient experienced substantial tumor reduction with dose adjustments due to adverse effects, indicating the potential efficacy of capmatinib in treating CUP with MET amplification.
|
| キーワード | MET amplification
capmatinib
MET inhibitors
cancer of unknown primary
MET exon 14 skipping
|
| 発行日 | 2025-12-01
|
| 出版物タイトル |
Internal Medicine
|
| 巻 | 64巻
|
| 号 | 23号
|
| 出版者 | Japanese Society of Internal Medicine
|
| 開始ページ | 3460
|
| 終了ページ | 3464
|
| ISSN | 0918-2918
|
| NCID | AA10827774
|
| 資料タイプ |
学術雑誌論文
|
| 言語 |
英語
|
| OAI-PMH Set |
岡山大学
|
| 著作権者 | © 2025 by The Japanese Society of Internal Medicine
|
| 論文のバージョン | publisher
|
| PubMed ID | |
| DOI | |
| Web of Science KeyUT | |
| 関連URL | isVersionOf https://doi.org/10.2169/internalmedicine.5028-24
|
| ライセンス | https://creativecommons.org/licenses/by-nc-nd/4.0/
|